Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

NCT00126763 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
105
Enrollment
INDUSTRY
Sponsor class

Stopped PK results suggested product did not meet requirement for further development.

Conditions

Interventions

Sponsor

ZARS Pharma Inc.